Cardiometabolic Genome Project Case Presentation (July 28, 2023)

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Cardiometabolic Genome Project Case Discussion and Clinical Specialists Meeting will take place on Friday, July 28, 2023 at 2:00 p.m. Attendance will only be available virtually through Zoom.

Activity Information

Needs Statement

Cardiologists, endocrinologists, and clinical geneticists need to receive regular updates on technological advances in genetic testing for cardiovascular, cardiometabolic, and related diseases. This series will focus on case discussions among faculty involved in the Cardiometabolic Genome Project at Baylor College of Medicine and clinical specialists and subspecialists affiliated with DHR Health in the Rio Grande Valley who are participating in the Cardiometabolic Precision Health Pilot in South Texas. The aim of the series is to enhance knowledge of cardiometabolic genetic testing, promote the application of genomic medicine tools in clinical settings, overcome barriers to point-of-care genetic counseling and testing, advance cardiovascular and cardiometabolic care, and improve patient outcomes.

Educational Objectives

At the conclusion of the session, the participants should be able to:

  • Identify appropriate patient cases for cardiometabolic genetic testing.
  • Interpret a genetic report, including the results of the gene panel, lipoprotein (a) variants identified, and the pharmacogenomics related to cardiometabolic care.
  • Counsel a patient on the results of a cardiometabolic genetic report.

Target Audience

Professional Categories

  • Physicians
  • Fellows
  • Other Health Professionals

Specialties

  • Medical Genetics and Genomics

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Directors

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine
  2. Michael Fordis, M.D.

    Michael Fordis, M.D.

    Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
    Baylor College of Medicine

Moderator

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Christie Mitchell Ballantyne, M.D.

    Christie Mitchell Ballantyne, M.D.

    Professor, Chief of Cardiology and Cardiovascular Research
    Baylor College of Medicine

    Disclosure:
    • Research Support: Abbott Diagnostic; Akcea; Amgen; Arrowhead; Esperion; Ionis; Merck; New Amsterdam; Novartis; Novo Nordisk; Regeneron; Roche Diagnostic
    • Consultancy: 89Bio; Abbott Diagnostics; Alnylam Pharmaceuticals; Althera; Amarin; Amgen; Arrowhead; AstraZeneca; Denka Seiken; Esperion; Genentech; Gilead; Illumina; Ionis; Matinas BioPharma, Inc.; Merck; New Amsterdam; Novartis; Novo Nordisk; Pfizer; Regeneron; Roche Diagnostic

Activity Directors

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Michael Fordis, M.D.

    Michael Fordis, M.D.

    Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Michael Fordis, M.D.

    Michael Fordis, M.D.

    Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Ruchi Gaba, M.D

    Ruchi Gaba, M.D

    Associate Professor of Endocrinology
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Jason King, Ph.D. Placeholder Image

    Jason King, Ph.D.

    Associate Director, Center for Collaborative and Interactive Technologies
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Ginger Metcalf Placeholder Image

    Ginger Metcalf

    Executive Director of Research Administration
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Moderator

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Christie Mitchell Ballantyne, M.D.

Christie Mitchell Ballantyne, M.D.

Professor, Chief of Cardiology and Cardiovascular Research Baylor College of Medicine

Health Topics

You May Also Be Interested In

On Demand
Precision Medicine Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit No credit is available for this activity
On Demand
Clinical Genetics Conference
Activity duration: 1 hr
Activity Available On Demand
Credit No credit is available for this activity
On Demand (Coming Soon)
Cardiometabolic Genome Project Case Discussion and Clinical Specialists Meeting
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available